The Russian Direct Investment Fund (RDIF) and Serum Institute of India (SII) on Tuesday announced plans to start producing of the Russian vaccine Sputnik V against the coronavirus, with the first batch to be produced at SII's facilities in September.
The companies intend to produce over 300 million doses of the vaccine in India per year.
As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the Sputnik V jab. After the approval by the Drug Controller General of India (DCGI), the cultivation process has begun.
"RDIF is delighted to cooperate with Serum Institute of India, the world's largest vaccine manufacturer. This strategic partnership is a major step to substantially increase our production capabilities demonstrating a perfect example of joining forces and expertise to save lives both in India and around the world. With technology transfer underway we expect the first batches of the vaccine to be produced jointly with SII in coming months," said Kirill Dmitriev, CEO of the Russian Direct Investment Fund, in a statement.
"I am delighted to partner with RDIF to manufacture the Sputnik vaccine. We hope to make millions of doses in the coming months with trial batches starting in the month of September. With high efficacy and a good safety profile, it is critical that the Sputnik vaccine is accessible in full measure for people across India and the world. Given the uncertainty of the virus, it is important for international institutes, and governments to collaborate and further bolster up our fight against the pandemic,a added Adar Poonawalla, CEO of Serum Institute of India.
Sputnik V was registered in India under the emergency use authorisation procedure on April 12 and vaccination against coronavirus with the Russian vaccine started on May 14. It was the third vaccine to be cleared for immunisation programme in India after Covaxin and Covishield.
The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years. The vaccine is two-shot and studies have shown it to be 97.6 per cent effective against Covid-19. It is priced less than $10 per shot, making it affordable around the world.
India is the leading production hub for production of Sputnik vaccine. RDIF had earlier reached agreements with a number of pharmaceutical companies in India -- Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech and Morepen -- for production of the Russian vaccine.
Sputnik V vaccine has, so far, been registered in 67 countries globally with a total population of over 3.5 billion people.
Agartala-Akhaura Railway link, Maitri Setu to be operational soon: CM
Chief Minister Prof. Dr. Manik Saha announced on Friday that the Maitri Setu and the Agartala-Akhaura Railway Link will soon be operational.
CM urges clubs to maintain blood group lists for emergency use
Chief Minister Prof. Dr. Manik Saha on Friday urged social clubs in the state to maintain a list of blood groups, which can be used if any person is in need of blood.
Tripura: Two held for killing family head after victim fails to pay premium for son’s bike
In a horrific crime, a woman and her son were arrested for allegedly murdering middle-aged Haribol Biswas, a daily wage earner, after he expressed his inability to pay the premium for his son’s bike, police said on Friday.
Swati Maliwal's 'after-assault' video surfaces, being told to move out
Four days after the assault on Aam Aadmi Party (AAP) RS MP Swati Maliwal at Delhi CM’s residence, the chilling details of the incident have started to surface, with the lodging of the First Information Report (FIR) and subsequently the surfacing of alleged video of the incident.
Economic priorities will have to align with our strategic interests: EAM Jaishankar
Addressing the 'CII Annual Business Summit 2024' in the capital, EAM Jaishankar said the embassies will continue to extend their fullest support to the economic and employment interests abroad.
Tis Hazari court records Swati Maliwal’s statement
Aam Aadmi Party (AAP) Rajya Sabha member Swati Maliwal on Friday recorded her statement before the Tis Hazari court in Delhi in connection with the alleged assault on her at Chief Minister Arvind Kejriwal's official residence.
Congress’ mission is to win 50 seats now: PM Modi
Prime Minister Narendra Modi said on Friday that the Congress has now launched ‘Mission 50’ and is working to win a minimum of 50 seats only in the ongoing Lok Sabha elections.
Pulled my shirt up, punched me in chest and stomach: Chilling details in Swati Maliwal’s FIR
Swati Maliwal, the Aam Aadmi Party (AAP) Rajya Sabha member on Friday formally lodged a complaint with Delhi Police, revealing the extent of harassment and torture she faced at the Delhi Chief Minister Arvind Kejriwal’s residence.